Uppsala, 20240820 — Deversify Health AB (publ) ("Deversify"), which was recently listed on Nasdaq First North through a reverse acquisition, has signed a distribution agreement with Belgian pharmacy chain Newpharma SRL ("Newpharma") and their subsidiary Smart Value Distribution SRL for resale of Acetrack in central Western Europe. As far as resellers are concerned, Deversify currently only has such dealers in Sweden and offers Acetrack in the rest of Europe and the world exclusively through its own channels. The agreement with Newpharma means that two new milestones are achieved: part resale in central Europe and part distribution to end customers through digital and physical pharmacies. Newpharma is a fast-growing pharmacy chain with e-commerce in France, Belgium, the Netherlands, Luxembourg, Germany, Austria and Switzerland and was among other things voted France's best e-pharmacy in 2023. Their distribution company also delivers to other pharmacies around the region, in in most cases physical pharmacies. Newpharma also has a close connection with Yooboo, which is a Belgian opinion leader around the importance of lifestyle changes. "The fact that we are starting to find local sales channels and logistics partners out in continental Europe is a good sign that the demand for solutions such as Acetrack offers is rising," says Anders Murman, CEO of Deversify. "The fact that it also comes from an actor such as Newpharma, with a modern approach to lifestyle changes and which tries to change how the pharmacy's role in society can become more holistic, is gratifying as it is completely in line with Deversify's view of how health improvements can be achieved without necessarily always rely on medicine."